Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (96)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Miller, M. P.
Right arrow Articles by Kumar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, M. P.
Right arrow Articles by Kumar, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 21 2319-2328
© 2001 Oxford University Press

Understanding human disease mutations through the use of interspecific genetic variation

Mark P. Miller and Sudhir Kumar+

Department of Biology, Arizona State University, Tempe, AZ 85287-1501, USA

Data on replacement mutations in genes of disease patients exist in a variety of online resources. In addition, genome sequencing projects and individual gene sequencing efforts have led to the identification of disease gene homologs in diverse metazoan species. The availability of these two types of information provides unique opportunities to investigate factors that are important in the development of genetically based disease by contrasting long and short-term molecular evolutionary patterns. Therefore, we conducted an analysis of disease-associated human genetic variation for seven disease genes: the cystic fibrosis transmembrane conductance regulator, glucose-6-phosphate dehydrogenase, the neural cell adhesion molecule L1, phenylalanine hydroxylase, paired box 6, the X-linked retinoschisis gene and TSC2/tuberin. Our analyses indicate that disease mutations show definite patterns when examined from an evolutionary perspective. Human replacement mutations resulting in disease are overabundant at amino acid positions most conserved throughout the long-term history of metazoans. In contrast, human polymorphic replacement mutations and silent mutations are randomly distributed across sites with respect to the level of conservation of amino acid sites within genes. Furthermore, disease-causing amino acid changes are of types usually not observed among species. Using Grantham’s chemical difference matrix, we find that amino acid changes observed in disease patients are far more radical than the variation found among species and in non-diseased humans. Overall, our results demonstrate the usefulness of evolutionary analyses for understanding patterns of human disease mutations and underscore the biomedical significance of sequence data currently being generated from various model organism genome sequencing projects.

+ To whom correspondence should be addressed. Tel: +1 480 727 6949; Fax: +1 480 965 2519; Email: s.kumar@asu.eduPresent address:Mark P. Miller, Department of Fisheries and Wildlife, Utah State University, Logan, UT 84322-5210, USA


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
E. Errasti-Murugarren, P. Cano-Soldado, M. Pastor-Anglada, and F. J. Casado
Functional Characterization of a Nucleoside-Derived Drug Transporter Variant (hCNT3C602R) Showing Altered Sodium-Binding Capacity
Mol. Pharmacol., February 1, 2008; 73(2): 379 - 386.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Sandelin, A. Nordlund, P. M. Andersen, S. S. L. Marklund, and M. Oliveberg
Amyotrophic Lateral Sclerosis-associated Copper/Zinc Superoxide Dismutase Mutations Preferentially Reduce the Repulsive Charge of the Proteins
J. Biol. Chem., July 20, 2007; 282(29): 21230 - 21236.
[Abstract] [Full Text] [PDF]

Home page
 Protein Eng Des SelHome page
J. Thusberg and M. Vihinen
The structural basis of hyper IgM deficiency - CD40L mutations
Protein Eng. Des. Sel., March 1, 2007; 20(3): 133 - 141.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. M. Goldstein, M. Chan, M. Harland, E. M. Gillanders, N. K. Hayward, M.-F. Avril, E. Azizi, G. Bianchi-Scarra, D. T. Bishop, B. Bressac-de Paillerets, et al.
High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL.
Cancer Res., October 15, 2006; 66(20): 9818 - 9828.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
T. Lang, M. Haberl, D. Jung, A. Drescher, R. Schlagenhaufer, A. Keil, E. Mornhinweg, B. Stieger, G. A. Kullak-Ublick, and R. Kerb
Genetic Variability, Haplotype Structures, and Ethnic Diversity of Hepatic Transporters MDR3 (ABCB4) and Bile Salt Export Pump (ABCB11)
Drug Metab. Dispos., September 1, 2006; 34(9): 1582 - 1599.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. G. Randles, I. Lappalainen, S. B. Fowler, B. Moore, S. J. Hamill, and J. Clarke
Using Model Proteins to Quantify the Effects of Pathogenic Mutations in Ig-like Proteins
J. Biol. Chem., August 25, 2006; 281(34): 24216 - 24226.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. S. Sullivan, S. J. Bowne, D. G. Birch, D. Hughbanks-Wheaton, J. R. Heckenlively, R. A. Lewis, C. A. Garcia, R. S. Ruiz, S. H. Blanton, H. Northrup, et al.
Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3052 - 3064.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
L. Conde, J. M. Vaquerizas, H. Dopazo, L. Arbiza, J. Reumers, F. Rousseau, J. Schymkowitz, and J. Dopazo
PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes.
Nucleic Acids Res., July 1, 2006; 34(Web Server issue): W621 - W625.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
E. Mathe, M. Olivier, S. Kato, C. Ishioka, P. Hainaut, and S. V. Tavtigian
Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods
Nucleic Acids Res., March 6, 2006; 34(5): 1317 - 1325.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
T. J. Urban, R. Sebro, E. H. Hurowitz, M. K. Leabman, I. Badagnani, L. L. Lagpacan, N. Risch, and K. M. Giacomini
Functional genomics of membrane transporters in human populations
Genome Res., February 1, 2006; 16(2): 223 - 230.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
N. Lopez-Bigas, B. J. Blencowe, and C. A. Ouzounis
Highly consistent patterns for inherited human diseases at the molecular level
Bioinformatics, February 1, 2006; 22(3): 269 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. F. Rudd, R. D. Williams, E. L. Webb, S. Schmidt, G. S. Sellick, and R. S. Houlston
The Predicted Impact of Coding Single Nucleotide Polymorphisms Database
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2598 - 2604.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. D. Jones and D. J. Begun
Parallel evolution of chimeric fusion genes
PNAS, August 9, 2005; 102(32): 11373 - 11378.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
E. A. Stone and A. Sidow
Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity
Genome Res., July 1, 2005; 15(7): 978 - 986.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
L. Conde, J. M. Vaquerizas, C. Ferrer-Costa, X. de la Cruz, M. Orozco, and J. Dopazo
PupasView: a visual tool for selecting suitable SNPs, with putative pathological effect in genes, for genotyping purposes
Nucleic Acids Res., July 1, 2005; 33(suppl_2): W501 - W505.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
L M Messiaen and K Wimmer
Pitfalls of automated comparative sequence analysis as a single platform for routine clinical testing for NF1
J. Med. Genet., May 1, 2005; 42(5): e25 - e25.
[Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Balasubramanian, Y. Xia, E. Freinkman, and M. Gerstein
Sequence variation in G-protein-coupled receptors: analysis of single nucleotide polymorphisms
Nucleic Acids Res., March 22, 2005; 33(5): 1710 - 1721.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Wu, S. R. Hinson, A. Ohashi, D. Farrugia, P. Wendt, S. V. Tavtigian, A. Deffenbaugh, D. Goldgar, and F. J. Couch
Functional Evaluation and Cancer Risk Assessment of BRCA2 Unclassified Variants
Cancer Res., January 15, 2005; 65(2): 417 - 426.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Sivendran, D. Patterson, E. Spiegel, I. McGown, D. Cowley, and R. F. Colman
Two Novel Mutant Human Adenylosuccinate Lyases (ASLs) Associated with Autism and Characterization of the Equivalent Mutant Bacillus subtilis ASL
J. Biol. Chem., December 17, 2004; 279(51): 53789 - 53797.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
O. M. Sinilnikova, S. M. Ginolhac, C. Magnard, M. Leone, O. Anczukow, D. Hughes, K. Moreau, D. Thompson, C. Coutanson, J. Hall, et al.
Acetyl-CoA carboxylase {alpha} gene and breast cancer susceptibility
Carcinogenesis, December 1, 2004; 25(12): 2417 - 2424.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. D. Thomas and A. Kejariwal
Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: Evolutionary evidence for differences in molecular effects
PNAS, October 26, 2004; 101(43): 15398 - 15403.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
V Abkevich, A Zharkikh, A M Deffenbaugh, D Frank, Y Chen, D Shattuck, M H Skolnick, A Gutin, and S V Tavtigian
Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation
J. Med. Genet., July 1, 2004; 41(7): 492 - 507.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
L. Conde, J. M. Vaquerizas, J. Santoyo, F. Al-Shahrour, S. Ruiz-Llorente, M. Robledo, and J. Dopazo
PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level
Nucleic Acids Res., July 1, 2004; 32(suppl_2): W242 - W248.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
N. Lopez-Bigas and C. A. Ouzounis
Genome-wide identification of genes likely to be involved in human genetic disease
Nucleic Acids Res., June 4, 2004; 32(10): 3108 - 3114.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. H. Gray, L. M. Mangravite, R. P. Owen, T. J. Urban, W. Chan, E. J. Carlson, C. C. Huang, M. Kawamoto, S. J. Johns, D. Stryke, et al.
Functional and Genetic Diversity in the Concentrative Nucleoside Transporter, CNT1, in Human Populations
Mol. Pharmacol., March 1, 2004; 65(3): 512 - 519.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. K. Leabman, C. C. Huang, J. DeYoung, E. J. Carlson, T. R. Taylor, M. de la Cruz, S. J. Johns, D. Stryke, M. Kawamoto, T. J. Urban, et al.
Natural variation in human membrane transporter genes reveals evolutionary and functional constraints
PNAS, May 13, 2003; 100(10): 5896 - 5901.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
G. M. Cooper, M. Brudno, N. C. S. Program, E. D. Green, S. Batzoglou, and A. Sidow
Quantitative Estimates of Sequence Divergence for Comparative Analyses of Mammalian Genomes
Genome Res., May 1, 2003; 13(5): 813 - 820.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.